These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25750273)

  • 1. The effect of silibinin in enhancing toxicity of temozolomide and etoposide in p53 and PTEN-mutated resistant glioma cell lines.
    Elhag R; Mazzio EA; Soliman KF
    Anticancer Res; 2015 Mar; 35(3):1263-9. PubMed ID: 25750273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
    Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
    Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy.
    Qian X; Ren Y; Shi Z; Long L; Pu P; Sheng J; Yuan X; Kang C
    Mol Pharm; 2012 Sep; 9(9):2636-45. PubMed ID: 22853427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas.
    He W; Liu R; Yang SH; Yuan F
    Anticancer Drugs; 2015 Mar; 26(3):293-300. PubMed ID: 25535979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells.
    Ananta JS; Paulmurugan R; Massoud TF
    Mol Pharm; 2015 Dec; 12(12):4509-17. PubMed ID: 26559642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equinatoxin II potentiates temozolomide- and etoposide-induced glioblastoma cell death.
    Kahn SA; Biasoli D; Garcia C; Geraldo LH; Pontes B; Sobrinho M; Frauches AC; Romão L; Soletti RC; Assunção Fdos S; Tovar-Moll F; de Souza JM; Lima FR; Anderluh G; Moura-Neto V
    Curr Top Med Chem; 2012; 12(19):2082-93. PubMed ID: 23167797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells.
    Cufí S; Bonavia R; Vazquez-Martin A; Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Martin-Castillo B; Barrajón-Catalán E; Visa J; Segura-Carretero A; Bosch-Barrera J; Joven J; Micol V; Menendez JA
    Food Chem Toxicol; 2013 Oct; 60():360-8. PubMed ID: 23916468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin reverses drug resistance in human small-cell lung carcinoma cells.
    Sadava D; Kane SE
    Cancer Lett; 2013 Oct; 339(1):102-6. PubMed ID: 23879966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of temozolomide and Taxol exerts a synergistic inhibitory effect on Taxol‑resistant glioma cells via inhibition of glucose metabolism.
    Guan DG; Chen HM; Liao SF; Zhao TZ
    Mol Med Rep; 2015 Nov; 12(5):7705-11. PubMed ID: 26459853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.
    Gokturk D; Kelebek H; Ceylan S; Yilmaz DM
    Turk Neurosurg; 2018; 28(1):13-18. PubMed ID: 28191621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide.
    Conway GE; Casey A; Milosavljevic V; Liu Y; Howe O; Cullen PJ; Curtin JF
    Br J Cancer; 2016 Feb; 114(4):435-43. PubMed ID: 26882067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells.
    Inaba N; Kimura M; Fujioka K; Ikeda K; Somura H; Akiyoshi K; Inoue Y; Nomura M; Saito Y; Saito H; Manome Y
    Anticancer Res; 2011 May; 31(5):1653-8. PubMed ID: 21617223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H; Bousserouel S; Gossé F; Raul F
    Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
    Albanese C; Alzani R; Amboldi N; Degrassi A; Festuccia C; Fiorentini F; Gravina G; Mercurio C; Pastori W; Brasca M; Pesenti E; Galvani A; Ciomei M
    Br J Pharmacol; 2013 May; 169(1):156-66. PubMed ID: 23347136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting enhances the response of glioma to chemo- and radiotherapy.
    Safdie F; Brandhorst S; Wei M; Wang W; Lee C; Hwang S; Conti PS; Chen TC; Longo VD
    PLoS One; 2012; 7(9):e44603. PubMed ID: 22984531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Asparaginase
    Sanghez V; Chen M; Li S; Chou TF; Iacovino M; Lin HJ; Lasky JL; Panosyan EH
    Anticancer Res; 2018 May; 38(5):2627-2634. PubMed ID: 29715082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of galectin-1 involvement in glioma chemoresistance.
    Le Mercier M; Lefranc F; Mijatovic T; Debeir O; Haibe-Kains B; Bontempi G; Decaestecker C; Kiss R; Mathieu V
    Toxicol Appl Pharmacol; 2008 Jun; 229(2):172-83. PubMed ID: 18313712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin augments survival of glioma cells after radiation and temozolomide.
    Hassouna I; Sperling S; Kim E; Schulz-Schaeffer W; Rave-Fränk M; Hasselblatt M; Jelkmann W; Giese A; Ehrenreich H
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):927-34. PubMed ID: 19014782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.